Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia

por Zhao, Xujie, Wang, Ping, Diedrich, Jonathan D., Smart, Brandon, Reyes, Noemi, Yoshimura, Satoshi, Zhang, Jingliao, Yang, Wentao, Barnett, Kelly, Xu, Beisi, Li, Zhenhua, Huang, Xin, Yu, Jiyang, Crews, Kristine, Yeoh, Allen Eng Juh, Konopleva, Marina, Wei, Chia-Lin, Pui, Ching-Hon, Savic, Daniel, Yang, Jun J.
Publicado 2022

Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia Cells

por Rowland, Lauren, Smart, Brandon, Brown, Anthony, Dettorre, Gino M., Gocho, Yoshihiro, Hunt, Jeremy, Yang, Wenjian, Yoshimura, Satoshi, Reyes, Noemi, Du, Guoqing, John, August, Maxwell, Dylan, Stock, Wendy, Kornblau, Steven, Relling, Mary V., Inaba, Hiroto, Pui, Ching-Hon, Bourquin, Jean-Pierre, Karol, Seth E., Mullighan, Charles G., Evans, William E., Yang, Jun J., Crews, Kristine R.
Publicado 2023